OBI CEO Dr. Heidi Wang Invited to Speak at Biologics World Taiwan 2026 on Global Drug Regulatory Strategies

OBI Pharma (4174.TWO) announced that its Chief Executive Officer, Dr. Heidi Wang, attended Biologics World Taiwan 2026, held in Taipei on March 25–26. She delivered a presentation at the conference, sharing practical insights into the drug development process and global regulatory strategies.